The Raptiva Pregnancy Registry was a prospective observational study established to obtain
data on pregnancy outcomes of women who were exposed to Raptiva.
Any patient who has used Raptiva within 6 weeks prior to conception or during her
pregnancy may be included in the Registry. Enrollment is based on Raptiva exposure,
whether inadvertent or deliberate, in relation to pregnancy. Enrollment should occur as
early as possible during the pregnancy and must occur prior to knowledge of pregnancy